The management of Peyronie's disease.
Peyronie's disease has no known cause; recent understanding of the molecular mechanisms involved and the development of an animal model will aid the medical management of early disease. The medical management of chronic disease is futile as the delicate tunical architecture cannot regenerate. Surgical correction of the penile deformity is required in a minority of patients, and a choice lies between a Nesbit operation and a plaque incision and venous patch in patients who are concerned with penile shortening.
Ralph
D J
DJ
St Peter's Hospitals and The Institute Of Urology, London, UK. dralph@andrology.co.uk
Minhas
S
S
D010129:4-Aminobenzoic Acid / Q000008:administration & dosage; D003078:Colchicine / Q000008:administration & dosage; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008096:Lithotripsy / Q000379:methods; D008297:Male; D010411:Penile Induration / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D015917:Penile Prosthesis; D010413:Penis / Q000601:surgery; D011994:Recombinant Proteins; D013629:Tamoxifen / Q000008:administration & dosage; D014700:Verapamil / Q000008:administration & dosage; D014810:Vitamin E / Q000008:administration & dosage
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D013629:Tamoxifen; D014810:Vitamin E; D014700:Verapamil; D003078:Colchicine; D010129:4-Aminobenzoic Acid